Issue 1   |  16 February 2021 

 

Study Overview
The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.

 

Meet the Investigators

 

Progress Updates

 

 

Timeline

Available now...

Background and Rationale video available now;
https://www.tracktrial.org/background-and-rationale/